We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
-0.25%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.7B
AUM Growth
-$819M
Cap. Flow
-$246M
Cap. Flow %
-1.24%
Top 10 Hldgs %
34.79%
Holding
645
New
74
Increased
167
Reduced
252
Closed
94

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$220M
2
HON icon
Honeywell
HON
+$207M
3
NWL icon
Newell Brands
NWL
+$158M
4
T icon
AT&T
T
+$143M
5
AAPL icon
Apple
AAPL
+$136M

Sector Composition

Rank Sector Weight
1 Healthcare 19.13%
2 Communication Services 18.44%
3 Technology 18.04%
4 Industrials 12.35%
5 Consumer Discretionary 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCTY
426
DELISTED
SolarCity Corporation
SCTY
$425K ﹤0.01%
17,275
VIPS icon
427
Vipshop
VIPS
$6.94B
$413K ﹤0.01%
32,072
DBVT
428
DBV Technologies
DBVT
$825M
$409K ﹤0.01%
1,257
-1,681
-57% -$472K
VLRS
429
Controladora Vuela Compania de Aviacion
VLRS
$906M
$402K ﹤0.01%
+19,100
New +$352K
ARIA
430
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$396K ﹤0.01%
+62,000
New +$347K
LNN icon
431
Lindsay Corp
LNN
$1.16B
$395K ﹤0.01%
5,510
IMOS
432
ChipMOS TECHNOLOGIES
IMOS
$1.93B
$383K ﹤0.01%
20,020
BAP icon
433
Credicorp
BAP
$31.1B
$378K ﹤0.01%
2,887
-1,202
-29% -$132K
BLCM
434
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$370K ﹤0.01%
3,960
-200
-5% -$21.8K
OTIC
435
DELISTED
Otonomy, Inc.
OTIC
$345K ﹤0.01%
23,150
-5,550
-19% -$87.2K
ICPT
436
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$312K ﹤0.01%
2,425
-24,422
-91% -$2.88M
EC icon
437
Ecopetrol
EC
$32.3B
$294K ﹤0.01%
+34,200
New +$241K
M icon
438
Macy's
M
$6.37B
$261K ﹤0.01%
5,923
+5,320
+882% +$220K
CMS icon
439
CMS Energy
CMS
$23B
$255K ﹤0.01%
+6,000
New +$235K
NI icon
440
NiSource
NI
$22.3B
$247K ﹤0.01%
+10,500
New +$225K
WEC icon
441
WEC Energy
WEC
$37.4B
$244K ﹤0.01%
4,063
-5,337
-57% -$299K
ARCT icon
442
Arcturus Therapeutics
ARCT
$165M
$238K ﹤0.01%
8,957
-16,143
-64% -$547K
RGNX icon
443
Regenxbio
RGNX
$664M
$194K ﹤0.01%
+18,000
New +$230K
RDHL
444
Redhill Biopharma
RDHL
$3.95M
$190K ﹤0.01%
16
-17
-52% -$178K
ADAP
445
DELISTED
Adaptimmune Therapeutics
ADAP
$187K ﹤0.01%
23,045
-35,150
-60% -$287K
CMRX
446
DELISTED
Chimerix, Inc.
CMRX
$185K ﹤0.01%
36,150
+3,000
+9% +$19.6K
ONCE
447
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$177K ﹤0.01%
+6,000
New +$189K
MDVN
448
DELISTED
MEDIVATION, INC.
MDVN
$166K ﹤0.01%
3,610
+3,500
+3,182% +$127K
TERP
449
DELISTED
TerraForm Power, Inc
TERP
$153K ﹤0.01%
17,705
SUPN icon
450
Supernus Pharmaceuticals
SUPN
$2.71B
$137K ﹤0.01%
+9,000
New +$117K

Similar funds

Fred Alger Management's Q1 2016 Portfolio in Review

As of Q1 2016, Fred Alger Management held 645 positions worth $19.7B, down 4% from $20.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Fred Alger Management's Q1 2016 filing shows 74 new, 167 increased, 252 reduced and 94 closed positions. Its largest new stake was Philip Morris: 912,296 shares worth $89.5M. The largest sale was Amazon, an estimated $186M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Communication Services and Technology.

  • Fred Alger Management's largest Q1 2016 buy was Philip Morris: 912,296 shares worth $89.5M.
  • Fred Alger Management added most to Paramount Global Class B in Q1 2016, an estimated $220M increase.
  • Fred Alger Management's biggest Q1 2016 reduction was Amazon, cutting an estimated $186M.
  • Fred Alger Management fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $184M.
  • Fred Alger Management's ten largest holdings make up 35% of its $19.7B portfolio in Q1 2016.
  • Fred Alger Management opened 74 new positions and closed 94 in Q1 2016.
  • Fred Alger Management's portfolio value fell 4% quarter-over-quarter to $19.7B.

Based on Fred Alger Management's 13F filing for Q1 2016, filed 16 May 2016.